HEADER TRANSFERASE 25-MAY-21 7ONS TITLE PARP1 CATALYTIC DOMAIN IN COMPLEX WITH ISOQUINOLONE-BASED INHIBITOR TITLE 2 (COMPOUND 16) COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (662-1101); COMPND 5 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 6 DNA ADP-RIBOSYLTRANSFERASE PARP1,NAD(+) ADP-RIBOSYLTRANSFERASE 1, COMPND 7 ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1,PROTEIN POLY-ADP- COMPND 8 RIBOSYLTRANSFERASE PARP1; COMPND 9 EC: 2.4.2.30,2.4.2.-; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS PARP INHIBITOR, SELECTIVITY, STRUCTURE-BASED DRUG DESIGN, SYNTHETIC KEYWDS 2 LETHAL THERAPY, ONCOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,A.BALAZS,D.BARRATT,M.BISTA,M.CHUBA,S.L.DEGORCE,P.DI AUTHOR 2 FRUSCIA,K.EMBREY,A.GHOSH,S.GILL,A.GUNNARSSON,S.HANDE,P.HEMSLEY, AUTHOR 3 T.D.HEIGHTMAN,G.ILLUZZI,J.LANE,C.LARNER,E.LEO,A.MADIN,S.MARTIN, AUTHOR 4 L.MCWILLIAMS,J.ORME,F.PACHL,M.PACKER,A.PIKE,A.D.STANISZEWSKA, AUTHOR 5 V.TALBOT,E.UNDERWOOD,G.J.VARNES,A.ZHANG,X.ZHENG,J.W.JOHANNES REVDAT 4 01-MAY-24 7ONS 1 REMARK REVDAT 3 27-OCT-21 7ONS 1 JRNL REVDAT 2 13-OCT-21 7ONS 1 JRNL REMARK REVDAT 1 15-SEP-21 7ONS 0 JRNL AUTH J.W.JOHANNES,A.BALAZS,D.BARRATT,M.BISTA,M.D.CHUBA, JRNL AUTH 2 S.COSULICH,S.E.CRITCHLOW,S.L.DEGORCE,P.DI FRUSCIA, JRNL AUTH 3 S.D.EDMONDSON,K.EMBREY,S.FAWELL,A.GHOSH,S.J.GILL, JRNL AUTH 4 A.GUNNARSSON,S.M.HANDE,T.D.HEIGHTMAN,P.HEMSLEY,G.ILLUZZI, JRNL AUTH 5 J.LANE,C.LARNER,E.LEO,L.LIU,A.MADIN,S.MARTIN,L.MCWILLIAMS, JRNL AUTH 6 M.J.O'CONNOR,J.P.ORME,F.PACHL,M.J.PACKER,X.PEI,A.PIKE, JRNL AUTH 7 M.SCHIMPL,H.SHE,A.D.STANISZEWSKA,V.TALBOT,E.UNDERWOOD, JRNL AUTH 8 J.G.VARNES,L.XUE,T.YAO,K.ZHANG,A.X.ZHANG,X.ZHENG JRNL TITL DISCOVERY OF JRNL TITL 2 5-{4-[(7-ETHYL-6-OXO-5,6-DIHYDRO-1,5-NAPHTHYRIDIN-3-YL) JRNL TITL 3 METHYL]PIPERAZIN-1-YL}- N -METHYLPYRIDINE-2-CARBOXAMIDE JRNL TITL 4 (AZD5305): A PARP1-DNA TRAPPER WITH HIGH SELECTIVITY FOR JRNL TITL 5 PARP1 OVER PARP2 AND OTHER PARPS. JRNL REF J.MED.CHEM. V. 64 14498 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34570508 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01012 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 80.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 52364 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 2584 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.31 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1048 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2649 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1003 REMARK 3 BIN R VALUE (WORKING SET) : 0.2618 REMARK 3 BIN FREE R VALUE : 0.3363 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.29 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 45 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5445 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 418 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.90270 REMARK 3 B22 (A**2) : 2.77570 REMARK 3 B33 (A**2) : -0.87300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.186 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.152 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.176 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.149 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5641 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7630 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2003 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 936 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5641 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 730 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6616 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 10.2021 43.8619 4.7997 REMARK 3 T TENSOR REMARK 3 T11: -0.0981 T22: 0.1151 REMARK 3 T33: -0.1643 T12: 0.0216 REMARK 3 T13: -0.0099 T23: -0.0101 REMARK 3 L TENSOR REMARK 3 L11: 0.5590 L22: 0.7540 REMARK 3 L33: 0.9675 L12: 0.0407 REMARK 3 L13: -0.1056 L23: -0.1161 REMARK 3 S TENSOR REMARK 3 S11: -0.0164 S12: 0.0118 S13: -0.0186 REMARK 3 S21: 0.0065 S22: 0.0131 S23: 0.0080 REMARK 3 S31: 0.0541 S32: -0.0358 S33: 0.0032 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 30.5510 26.9878 38.1118 REMARK 3 T TENSOR REMARK 3 T11: -0.0958 T22: 0.0060 REMARK 3 T33: -0.2196 T12: -0.0160 REMARK 3 T13: -0.0287 T23: 0.0014 REMARK 3 L TENSOR REMARK 3 L11: 0.8067 L22: 0.4961 REMARK 3 L33: 4.4341 L12: 0.1184 REMARK 3 L13: 0.2639 L23: -1.2083 REMARK 3 S TENSOR REMARK 3 S11: -0.0268 S12: -0.0242 S13: -0.0503 REMARK 3 S21: -0.0664 S22: 0.0498 S23: 0.0228 REMARK 3 S31: 0.3959 S32: -0.0581 S33: -0.0230 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ONS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1292116108. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97623 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53308 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 92.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 1.11500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.6 M AMMONIUM SULFATE, 0.1 M TRIS PH REMARK 280 8.5, PH 9.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.24350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.63000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.50550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.63000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.24350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.50550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 660 REMARK 465 SER A 661 REMARK 465 GLY B 660 REMARK 465 SER B 661 REMARK 465 GLY B 781 REMARK 465 SER B 782 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 662 CG CD CE NZ REMARK 470 LYS A 664 CG CD CE NZ REMARK 470 GLN A 728 CG CD OE1 NE2 REMARK 470 GLU A 809 CG CD OE1 OE2 REMARK 470 LYS B 684 CD CE NZ REMARK 470 GLN B 694 CG CD OE1 NE2 REMARK 470 THR B 824 OG1 CG2 REMARK 470 HIS B 826 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 849 CG CD CE NZ REMARK 470 LYS B 852 CG CD CE NZ REMARK 470 GLN B 853 CG CD OE1 NE2 REMARK 470 ASP B 914 CG OD1 OD2 REMARK 470 THR B1011 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 744 -34.84 -146.81 REMARK 500 HIS A 826 40.16 -107.18 REMARK 500 ASP A 914 75.01 -159.30 REMARK 500 LYS B 747 -167.90 -78.34 REMARK 500 HIS B 826 41.23 -97.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1368 DISTANCE = 6.43 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VKT A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VKT B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1103 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7ONR RELATED DB: PDB REMARK 900 RELATED ID: 7ONT RELATED DB: PDB DBREF 7ONS A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 7ONS B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 7ONS GLY A 660 UNP P09874 EXPRESSION TAG SEQADV 7ONS SER A 661 UNP P09874 EXPRESSION TAG SEQADV 7ONS ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 7ONS GLY B 660 UNP P09874 EXPRESSION TAG SEQADV 7ONS SER B 661 UNP P09874 EXPRESSION TAG SEQADV 7ONS ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 352 GLY SER LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 A 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 A 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 A 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 A 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 A 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 A 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 A 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 A 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 A 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 A 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 A 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 A 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 A 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 A 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 A 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 A 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 A 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 A 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 A 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 A 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 A 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 A 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 A 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 A 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 A 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 A 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 A 352 THR SEQRES 1 B 352 GLY SER LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 B 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 B 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 B 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 B 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 B 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 B 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 B 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 B 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 B 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 B 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 B 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 B 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 B 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 B 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 B 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 B 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 B 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 B 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 B 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 B 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 B 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 B 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 B 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 B 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 B 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 B 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 B 352 THR HET VKT A1101 27 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET VKT B1101 27 HET SO4 B1102 5 HET SO4 B1103 5 HETNAM VKT 7-[[4-(1,5-DIMETHYLIMIDAZOL-2-YL)PIPERAZIN-1- HETNAM 2 VKT YL]METHYL]-3-ETHYL-1~{H}-QUINOLIN-2-ONE HETNAM SO4 SULFATE ION FORMUL 3 VKT 2(C21 H27 N5 O) FORMUL 4 SO4 5(O4 S 2-) FORMUL 10 HOH *418(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 SER A 725 ILE A 740 1 16 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 ALA A 823 ASN A 827 5 5 HELIX 10 AB1 GLY A 843 LYS A 849 1 7 HELIX 11 AB2 PRO A 850 LYS A 852 5 3 HELIX 12 AB3 ARG A 865 THR A 867 5 3 HELIX 13 AB4 ASN A 868 GLY A 876 1 9 HELIX 14 AB5 PRO A 885 TYR A 889 5 5 HELIX 15 AB6 MET A 900 ASN A 906 1 7 HELIX 16 AB7 TYR A 907 HIS A 909 5 3 HELIX 17 AB8 PRO A 958 ASN A 961 5 4 HELIX 18 AB9 ASP A 993 ALA A 995 5 3 HELIX 19 AC1 PRO B 666 PHE B 677 1 12 HELIX 20 AC2 ASP B 678 TYR B 689 1 12 HELIX 21 AC3 PRO B 697 LEU B 701 5 5 HELIX 22 AC4 SER B 702 GLN B 722 1 21 HELIX 23 AC5 SER B 725 ILE B 740 1 16 HELIX 24 AC6 ASN B 754 GLY B 780 1 27 HELIX 25 AC7 ASP B 788 LEU B 797 1 10 HELIX 26 AC8 SER B 808 THR B 821 1 14 HELIX 27 AC9 ALA B 823 ASN B 827 5 5 HELIX 28 AD1 GLY B 843 LYS B 849 1 7 HELIX 29 AD2 PRO B 850 LYS B 852 5 3 HELIX 30 AD3 ARG B 865 THR B 867 5 3 HELIX 31 AD4 ASN B 868 GLY B 876 1 9 HELIX 32 AD5 PRO B 885 TYR B 889 5 5 HELIX 33 AD6 MET B 900 ASN B 906 1 7 HELIX 34 AD7 TYR B 907 HIS B 909 5 3 HELIX 35 AD8 PRO B 958 ASN B 961 5 4 HELIX 36 AD9 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LYS A1004 N ILE A 834 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N ARG A 858 O VAL A 924 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N LEU A 932 O LYS A 949 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 LEU B 831 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1007 -1 O LYS B1004 N ILE B 834 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N ILE B 919 O LEU B1003 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N LEU B 860 O GLY B 922 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N LEU B 932 O LYS B 949 SHEET 1 AA7 3 GLY B 974 SER B 976 0 SHEET 2 AA7 3 GLY B 952 PRO B 956 -1 N THR B 955 O ILE B 975 SHEET 3 AA7 3 LEU B 984 TYR B 986 1 O LEU B 985 N THR B 954 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 SITE 1 AC1 15 ASP A 766 ASN A 767 LEU A 769 ASP A 770 SITE 2 AC1 15 HIS A 862 GLY A 863 ASN A 868 ILE A 879 SITE 3 AC1 15 ALA A 880 TYR A 896 PHE A 897 SER A 904 SITE 4 AC1 15 TYR A 907 HOH A1230 HOH A1280 SITE 1 AC2 7 LYS A 903 LEU A 984 LEU A 985 TYR A 986 SITE 2 AC2 7 HOH A1211 HOH A1216 HOH A1391 SITE 1 AC3 6 GLU A 840 GLY A 843 GLU A 844 CYS A 845 SITE 2 AC3 6 GLN A 846 HOH A1254 SITE 1 AC4 4 ARG A 858 MET A 929 LYS A 949 HOH A1304 SITE 1 AC5 14 ASP B 766 ASN B 767 ASP B 770 HIS B 862 SITE 2 AC5 14 GLY B 863 ASN B 868 ARG B 878 ILE B 879 SITE 3 AC5 14 ALA B 880 TYR B 896 PHE B 897 SER B 904 SITE 4 AC5 14 TYR B 907 HOH B1227 SITE 1 AC6 5 LYS B 903 LEU B 984 LEU B 985 TYR B 986 SITE 2 AC6 5 HOH B1292 SITE 1 AC7 4 ARG B 858 MET B 929 LYS B 949 HOH B1286 CRYST1 48.487 93.011 163.260 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020624 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010751 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006125 0.00000